Edoxudine

This classification denotes an antiviral agent with the molecular formula C11H16N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 15ZQM81Y3R, chemically known as uridine, 2-deoxy-5-ethyl- but generally known as edoxudine, which bears US NIH Compound Identifier 1814. European Medicines Agency schedules Edoxudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06460MIG. The term EDOXUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules edoxudine in its Anatomical Therapeutic Chemical (ATC) Classification. EDOXUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule edoxudine under HS 29349990 and SITC 51579. As of Q4 2014, EDOXUDINE remains the US FDA Preferred Term for this commodity. Edoxudine bears US NLM identifiers UMLS ID C0115510 and NCI Concept Code C87662. SMILES: CCC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O.